Last reviewed · How we verify
TRD205
At a glance
| Generic name | TRD205 |
|---|---|
| Sponsor | Beijing Tide Pharmaceutical Co., Ltd |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- To Evaluate the Efficacy and Safety of TRD205 Tablets in the Treatment of Chronic Postoperative Neuralgia (PHASE2)
- Single and Multiple Ascending Doses and Food Effect Study of TRD205 in Healthy Volunteers (PHASE1)
- To Evaluate the Safety, Efficacy and Kinetic Characteristics of TRD205 Tablets for Postoperative Analgesia After Unilateral Hallux Valgus Orthopedic Surgery (PHASE1)
- To Evaluate the Safety, Efficacy and Kinetic Characteristics of TRD205 Tablets for Postoperative Analgesia After Unilateral Hip Arthroplasty (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- TRD205 CI brief — competitive landscape report
- TRD205 updates RSS · CI watch RSS
- Beijing Tide Pharmaceutical Co., Ltd portfolio CI